Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment
Jason Gotlib, Julia E. Maxson, Tracy I. George, et al.
Blood (2013) Vol. 122, Iss. 10, pp. 1707-1711
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

The genetic basis of myelodysplasia and its clinical relevance
Mario Cazzola, Matteo Giovanni Della Porta, Luca Malcovati
Blood (2013) Vol. 122, Iss. 25, pp. 4021-4034
Open Access | Times Cited: 329
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms
Laura Palomo, Manja Meggendorfer, Stephan Hütter, et al.
Blood (2020) Vol. 136, Iss. 16, pp. 1851-1862
Open Access | Times Cited: 151
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
Michael R. Savona, Luca Malcovati, Rami S. Komrokji, et al.
Blood (2015) Vol. 125, Iss. 12, pp. 1857-1865
Open Access | Times Cited: 172
Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies
Pankaj Dwivedi, Kenneth D. Greis
Experimental Hematology (2016) Vol. 46, pp. 9-20
Open Access | Times Cited: 134
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia
Carlo Gambacorti‐Passerini, Carla Donadoni, Andrea Parmiani, et al.
Blood (2014) Vol. 125, Iss. 3, pp. 499-503
Open Access | Times Cited: 128
Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia
Manja Meggendorfer, T. Haferlach, Tamara Alpermann, et al.
Haematologica (2014) Vol. 99, Iss. 12, pp. e244-e246
Open Access | Times Cited: 103
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
Tariq I. Mughal, Nicholas C.P. Cross, E. Padron, et al.
Haematologica (2015) Vol. 100, Iss. 9, pp. 1117-1130
Open Access | Times Cited: 98
Genomics of chronic neutrophilic leukemia
Julia E. Maxson, Jeffrey W. Tyner
Blood (2016) Vol. 129, Iss. 6, pp. 715-722
Open Access | Times Cited: 93
MDS overlap disorders and diagnostic boundaries
Tiffany Tanaka, Rafael Bejar
Blood (2019) Vol. 133, Iss. 10, pp. 1086-1095
Open Access | Times Cited: 80
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis
Haijiao Zhang, Beth Wilmot, Daniel Bottomly, et al.
Blood (2019) Vol. 134, Iss. 11, pp. 867-879
Open Access | Times Cited: 76
Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review
Mariana Miranda Sampaio, Maria Luísa Cordeiro Santos, Hanna Santos Marques, et al.
World Journal of Clinical Oncology (2021) Vol. 12, Iss. 2, pp. 69-94
Open Access | Times Cited: 56
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
Gonzalo Carreño‐Tarragona, Alberto Álvarez‐Larrán, Claire Harrison, et al.
Blood Advances (2023) Vol. 7, Iss. 9, pp. 1672-1681
Open Access | Times Cited: 25
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management
Natasha Szuber, Attilio Orazi, Ayalew Tefferi
American Journal of Hematology (2024) Vol. 99, Iss. 7, pp. 1360-1387
Closed Access | Times Cited: 13
Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia
Kim-Hien T. Dao, Magdolna Solti, Julia E. Maxson, et al.
Leukemia Research Reports (2014) Vol. 3, Iss. 2, pp. 67-69
Open Access | Times Cited: 74
Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia
Mrinal M. Patnaik, Daniela Barraco, Terra L. Lasho, et al.
American Journal of Hematology (2017) Vol. 92, Iss. 6, pp. 542-548
Open Access | Times Cited: 73
Genomics of Myeloproliferative Neoplasms
Katerina Zoi, Nicholas C.P. Cross
Journal of Clinical Oncology (2017) Vol. 35, Iss. 9, pp. 947-954
Open Access | Times Cited: 65
Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2023) Vol. 98, Iss. 4, pp. 681-689
Open Access | Times Cited: 21
Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms
Sanam Loghavi, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, et al.
Modern Pathology (2023) Vol. 37, Iss. 2, pp. 100397-100397
Closed Access | Times Cited: 17
Leukocytosis
Devon Chabot‐Richards, Tracy I. George
International Journal of Laboratory Hematology (2014) Vol. 36, Iss. 3, pp. 279-288
Open Access | Times Cited: 63
How I treat atypical chronic myeloid leukemia
Jason Gotlib
Blood (2016) Vol. 129, Iss. 7, pp. 838-845
Open Access | Times Cited: 60
Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable
Katerina Zoi, Nicholas C.P. Cross
International Journal of Hematology (2014) Vol. 101, Iss. 3, pp. 229-242
Open Access | Times Cited: 57
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth
Barbara Peter, Georg E. Winter, K. Blatt, et al.
Leukemia (2015) Vol. 30, Iss. 2, pp. 464-472
Open Access | Times Cited: 55
Time resolved quantitative phospho-tyrosine analysis reveals Bruton’s Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors
Pankaj Dwivedi, David E. Muench, Michael Wagner, et al.
Leukemia (2018) Vol. 33, Iss. 1, pp. 75-87
Open Access | Times Cited: 55
Chronic neutrophilic leukaemia and plasma cell‐related neutrophilic leukaemoid reactions
Barbara J. Bain, Shahzaib Ahmad
British Journal of Haematology (2015) Vol. 171, Iss. 3, pp. 400-410
Open Access | Times Cited: 54
CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML
Julia E. Maxson, Rhonda E. Ries, Yi-Cheng Wang, et al.
Blood (2016) Vol. 127, Iss. 24, pp. 3094-3098
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top